Top Buy
Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €61.00 | €79.55 | 30.417% |
TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €16.06 | €28.06 | 74.770% |
Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.53 | €35.43 | 38.775% |
Novavax Inc. | 6 | 2 | 4 | 1 | €12.73 | €49.80 | 291.109% |
EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €11.33 | €27.80 | 145.402% |
AnaptysBio Inc | 9 | 1 | 4 | 0 | €22.00 | €45.21 | 105.500% |
Cytokinetics Inc. | 26 | 1 | 3 | 0 | €53.50 | €84.57 | 58.078% |
Evolus Inc | 9 | 0 | 3 | 0 | €11.60 | €20.43 | 76.142% |
Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
MacroGenics Inc. | 11 | 1 | 3 | 1 | €3.92 | €12.42 | 217.118% |
XOMA Corp. | 6 | 0 | 3 | 0 | €24.00 | €68.78 | 186.580% |
Twist Bioscience Corp | 7 | 0 | 3 | 0 | €43.97 | €41.54 | -5.538% |
Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
Insmed Inc. | 15 | 1 | 3 | 1 | €23.60 | €42.72 | 80.998% |
G1 Therapeutics | 15 | 1 | 2 | 0 | €4.29 | €10.56 | 146.245% |
Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.25 | €10.00 | 21.286% |
Adverum Biotechnologies Inc. | 6 | 0 | 2 | 0 | €1.38 | €4.66 | 237.768% |
Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €67.50 | €100.00 | 48.148% |
Esperion Therapeutis.Inc. | 14 | 0 | 2 | 0 | €2.05 | €8.39 | 309.482% |
Biolife Solutions Inc | 2 | 0 | 2 | 0 | €18.90 | €32.00 | 69.312% |
Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.80 | €50.00 | 25.628% |
Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.27 | €11.05 | 109.704% |
Geron Corp. | 12 | 0 | 2 | 0 | €3.46 | €4.63 | 33.616% |
Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.60 | €45.98 | 29.157% |